Literature DB >> 15662151

Intramuscular ziprasidone in youth: a retrospective chart review.

Jud A Staller1.   

Abstract

OBJECTIVE: The aim of this study was to assess the tolerability and effectiveness of intramuscular ziprasidone in inpatient children and adolescents.
METHOD: A retrospective chart review was conducted of child and adolescent inpatients at a private psychiatric hospital in central New York between January 1, 2003 and August 30, 2003. Subjects who had received intramuscular ziprasidone were identified, and their age, gender, and dosage were recorded. Nursing-shift notes were reviewed to ascertain the need for repeat injection and for adverse reactions.
RESULTS: Forty-nine youths received intramuscular ziprasidone; 43 injections were 20 mg and 6 injections were 10 mg. Readministration within 4 hours was required in only 1 subject. No adverse events were recorded.
CONCLUSION: Intramuscular ziprasidone was well tolerated and effective for acutely agitated and aggressive inpatient youth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15662151     DOI: 10.1089/cap.2004.14.590

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  10 in total

Review 1.  Management of schizophrenia in children and adolescents: focus on pharmacotherapy.

Authors:  Gabriele Masi; Francesca Liboni
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

2.  Research strategies that result in optimal data collection from the patient medical record.

Authors:  Katherine E Gregory; Lucy Radovinsky
Journal:  Appl Nurs Res       Date:  2010-04-09       Impact factor: 2.257

3.  A methodology for conducting retrospective chart review research in child and adolescent psychiatry.

Authors:  Robin E Gearing; Irfan A Mian; Jim Barber; Abel Ickowicz
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2006-08

4.  Recommendations for pharmacological management of inpatient aggression in children and adolescents.

Authors:  Parikshit Deshmukh; Guarav Kulkarni; Drew Barzman
Journal:  Psychiatry (Edgmont)       Date:  2010-02

Review 5.  Pharmacologic management of acutely agitated pediatric patients.

Authors:  Loretta Sonnier; Drew Barzman
Journal:  Paediatr Drugs       Date:  2011-02-01       Impact factor: 3.022

6.  Focus on ziprasidone: a review of its use in child and adolescent psychiatry.

Authors:  Dean Elbe; Carlo G Carandang
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2008-11

7.  A meta-analysis of the risk of acute extrapyramidal symptoms with intramuscular antipsychotics for the treatment of agitation.

Authors:  Theodore D Satterthwaite; Daniel H Wolf; Robert A Rosenheck; Raquel E Gur; Stanley N Caroff
Journal:  J Clin Psychiatry       Date:  2008-12-02       Impact factor: 4.384

Review 8.  Collaborative problem solving (CPS) as a primary method of addressing acute pediatric pathological aggression along with other modalities.

Authors:  Gaurav Kulkarni; Parikshit Deshmukh; Drew Barzman
Journal:  Psychiatr Q       Date:  2010-06

9.  Treating persistent adolescent aggression.

Authors:  John Peterson; Christopher Sheldon
Journal:  Curr Treat Options Neurol       Date:  2006-09       Impact factor: 3.972

10.  Conventional intramuscular sedatives versus ziprasidone for severe agitation in adolescents: case-control study.

Authors:  William C Jangro; Horacio Preval; Robert Southard; Steven G Klotz; Andrew Francis
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2009-03-12       Impact factor: 3.033

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.